At the recent IMPAKT Breast Cancer Conference, 2 – 4th May, Brussels, ecancer´s Peter Goodwin talks to Ana Vivancos about her pioneering research in cancer genomics and work contributing to improved phase I clinical studies and best therapies for patients.
Related Posts
VHIO scientists eradicate lung tumours in a pre-clinical mouse model
Previous studies had already shown that Myc was a key protein in tumour development and had established how to inhibit…
09 Mar 2013
Date in the diary with Nature Reviews Cancer 29 June 15:00h – 16:15h
Taking place on Monday 29 June 2015, 15:00 – 16:15, we are delighted to announce that Senior Editor of Nature Reviews Cancer,…
15 Jun 2015
ICREA: promoting latest discovery to better elucidate cancer evolution and tumor heterogeneity
Considering cancer from an evolutionary perspective in order to better understand its vast complexity and clonal dynamics is undoubtedly opening…
09 Mar 2017
VHIO´s Javier Cortés joins The Lancet Oncology´s International Advisory Board 2014
Javier Cortés, Principal Investigator of VHIO´s Breast Cancer and Melanoma Group, Specialist Physician at the Oncology Department of the Vall…
28 Oct 2013
Joint Vall d’Hebron University Hospital and VHIO project announced as Hinnovar Award finalist
The Hinnovar awards, organized by Novartis in collaboration with ESADE and the Spanish Society of Health Directives (SEDISA), aim to…
22 Nov 2013
Molecular Oncology News and Views: VHIO-Fritz Bender Foundation International Symposium on Progress Towards Individualized Cancer Treatments, 07 – 09 November 2013
Molecular Oncology 8 (2014) 1-8 News and views Towards individualized cancer therapy: Challenges and prospects Ezzie Hutchinson ABSTRACT At the…
14 Feb 2014
FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer
Source: WIN Consortium VILLEJUIF, France–(BUSINESS WIRE)– WIN Consortium (WIN) received the US Food and Drug Administration (FDA)’s approval to start…
09 Aug 2017
VHIO awarded International Certification for Project Management in Cancer Biomedical Research
Fulfilling the requirements of the standard ISO 9001:2008, VHIO is one of the few research institutes in Europe to have…
06 Jun 2013
2015 RTICC Prize for Collaborative Research in Oncology awarded to VHIO´s Growth Factors Group
An initiative aimed at promoting collaborative research of excellence in oncology and, more specifically, recognizing the contributions of young cancer…
22 Oct 2015
World Breast Cancer Day 2013: marking seven years´ Breast Cancer Research Foundation support for VHIO
Joaquín Arribas, Director of Preclinical Research at VHIO, this week joined 165 of the world´s leading breast cancer researchers in…
16 Oct 2013
Immediate Call for Oustanding Principal Investigators in Basic/Translational Cancer Research & Immunology
The Vall d´Hebron Institute of Oncology (VHIO), invites immediate applications from outstanding individuals to establish and maintain energetic, independent and…
30 Dec 2013
Translational Research allows the development of personalized treatment for cancer
Today, we know much more about why a cell becomes cancerous and about which proteins and genes are responsible for this happening
07 Sep 2010
Affordable funding increase can save three million lives per year from cancer in low- and middle-income countries (LMICs) by 2030
Source: Union for International Cancer Control (UICC) New data projects that US$18 billion increase in funding per year by the…
04 Feb 2015
First Cleveland-Vall d´Hebron Workshop in Renal Cell Carcinoma
On 12 July 2012, internationally renowned experts in renal carcinoma, Dr. Brian Rini and Dr. Jorge García from the Cleveland…
11 Jul 2012
In partnership with leading organisations across the globe AECC declares 24 September as World Cancer Research Day
Today, a special roundtable, presided by Her Majesty Queen Letizia of Spain, President of the Spanish Association Against Cancer (AECC),…
22 Sep 2016
